SCHEMBL8407445

SCHEMBL8407445

O=C(O)c1ccc2c(c1)S(=O)(=O)OC2=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.54
TTR P02766 3/20 0.47
PTPRC P08575 2/20 0.46
KMT2A Q03164 6/20 0.44
POLB P06746 3/20 0.44
CA12 O43570 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
MEN1 O00255 5/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
SRD5A2 P31213 2/20 0.40
SRD5A1 P18405 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12403806 0.86 TTR (0.47) CHEK1TTRPTPRCKMT2APOLB
SCHEMBL8533479 0.85 CHEK1 (0.39) CHEK1TTRPTPRCKMT2AMEN1
SCHEMBL2706112 0.74 CHEK1 (0.69) CHEK1TTRPTPRCKMT2APOLB
SCHEMBL29789038 0.74 CHEK1 (0.69) CHEK1TTRPTPRCKMT2APOLB
SCHEMBL14199812 0.73 CHEK1 (0.84) CHEK1TTRPTPRCKMT2AMEN1
SCHEMBL576238 0.73 CA2 (0.39) CA12CA2CA4CA7CA9
SCHEMBL31365268 0.71 CHEK1 (0.65) CHEK1TTRPTPRCKMT2APOLB
SCHEMBL3399246 0.70 CA12 (0.59) CHEK1KMT2ACA12CA2CA4
SCHEMBL29643009 0.70 CA12 (0.59) CHEK1KMT2ACA12CA2CA4
SCHEMBL11547694 0.70 CHEK1 (0.84) CHEK1TTRPTPRCKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9745336-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2017-08-29 US disclosed
US-20140303003-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof APPLIED BIOSYSTEMS, LLC (US) 2014-10-09 US disclosed
US-7985602-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2011-07-26 US disclosed
US-7985602-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2011-07-26 US disclosed
US-20090093062-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof APPLERA CORPORATION (US) 2009-04-09 US disclosed
US-20090093062-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof APPLERA CORPORATION (US) 2009-04-09 US disclosed
US-7256292-B2 Fluorescent dye compounds, conjugates and uses thereof APPLERA CORPORATION (US) 2007-08-14 US disclosed
US-7256292-B2 Fluorescent dye compounds, conjugates and uses thereof APPLERA CORPORATION (US) 2007-08-14 US disclosed
US-5891970-A AMIDATION WITH 2-SULFOBENZOIC ANHYDRIDE NATIONAL SCIENCE COUNCIL OF REPUBLIC OF CHINA (TW) 1999-04-06 US disclosed
US-5462991-A Pthalein-type ROBOTTI KARLA M (US) 1995-10-31 US disclosed
US-5384411-A Phthalien dyes HEWLETT-PACKARD COMPANY (US) 1995-01-24 US disclosed
EP-0519198-A2 Immobilization of PH-sensitive dyes to solid supports Hewlett-Packard Company (US) 1992-12-23 EP disclosed
US-3996202-A Process for the preparation of sulfonate group containing aromatic polyamides HOECHST AKTIENGESELLSCHAFT (DT) 1976-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093062-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof GFPT1, SLC46A1, SLC7A5 CHEK1 3945/4885TTR 1843/4885PTPRC 3214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.